- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06906965
Effect of the Imera Cultivar Carob in Postprandial Glycemia (IMERACAROBGLUC)
April 4, 2025 updated by: Andriana C. Kaliora, Harokopio University
Impact of the Imera Carob Cultivar in Postprandial Glycemia
An acute randomized crossover study on the effect of a carob beverage on postprandial glycemic response
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is an acute randomized crossover study on the effect of an Imera cultivar carob beverage on postprandial glycemic response in healthy individuals as opposed to sucrose-based beverage containing sugar in alike concentration
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Attica
-
Kallithea, Attica, Greece, 17676
- Department of Nutrition and Dietetics, HarokopioUniversity of Athens
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- healthy male adults of normal body fat mass
Exclusion Criteria:
- obesity (according to body fat mass), type 1 Diabetes, hypertension and other cardiovascular diseases, thyroid disorder, liver, kidney, gastrointestinal disease, mental illness, use of nutraceutical supplements or natural products for weight loss and the background of dietitian/nutritionist.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Carob beverage
The participants consumed a carob beverage prepared with 30 g of Imera cultivar carob powder dissolved in water
|
The participants consumed a carob beverage made with 30gr of Imera carob cultivar powder in water
|
|
Active Comparator: Sucrose beverage
The participants consumed a sucrose beverage made containing 14 g of sugar, matched to the sugar concentration of the experimental beverage
|
The participants consumed a sucrose beverage made with 14gr of sugar in alike concentration with sugars in the experimental beverage
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postprandial glucose
Time Frame: 3 hours
|
Changes in glucose levels after the consumption of the beverage
|
3 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postprandial insulin
Time Frame: 3 hours
|
Changes in insulin levels after consuming the beverage
|
3 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 31, 2024
Primary Completion (Actual)
May 31, 2024
Study Completion (Actual)
September 30, 2024
Study Registration Dates
First Submitted
March 26, 2025
First Submitted That Met QC Criteria
March 26, 2025
First Posted (Actual)
April 2, 2025
Study Record Updates
Last Update Posted (Actual)
April 6, 2025
Last Update Submitted That Met QC Criteria
April 4, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- CAROB_GLUCOSE_147
- 016713 (Other Grant/Funding Number: Hellenic Foundation for Research and Innovation)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postprandial Glucose Regulation
-
Lund UniversitySwedish Foundation for Strategic ResearchCompleted
-
Lund UniversitySwedish Foundation for Strategic ResearchCompleted
-
Lund UniversitySwedish Foundation for Strategic ResearchCompleted
-
Lund UniversityAnti-Diabetic Food CentreCompletedPostprandial Blood Glucose RegulationSweden
-
Purdue UniversityNot yet recruitingPostprandial Metabolism | Insulin Response | Postprandial Glucose Response | Lactose Digestion
-
Wageningen UniversityCompletedGlucose Metabolism | Postprandial Glucose ResponsesNetherlands
-
NestléCompletedPostprandial Glucose ResponseSwitzerland
-
San Diego State UniversityCompletedPostprandial Blood GlucoseUnited States
-
Glycemic Index Laboratories, IncCanadian Center for Functional Medicine; InovoBiologic Inc.CompletedBlood Glucose, PostprandialCanada
-
Marjukka KolehmainenCompletedHyperglycemia | Blood Glucose, Postprandial | Blood Insulin, PostprandialFinland
Clinical Trials on Carob beverage
-
Harokopio UniversityCompleted
-
Harokopio UniversityCompleted
-
Toros UniversityNot yet recruitingCeliac Disease
-
Unilever R&DCompletedSatiety | AppetiteUnited Kingdom
-
University of CopenhagenCarlsberg Breweries A/SCompletedInsulin Resistance | Alcohol ConsumptionDenmark
-
Old Dominion UniversityTerminatedAnomalies GastrointestinalUnited States
-
Old Dominion UniversityCompletedImpaired ThermoregulationUnited States
-
GUAYAKI SUSTAINABLE RAINFOREST PRODUCTS, INC.Nlumn LLC; Alethios, Inc.RecruitingHealthy | Caffeine | Beverage IntakeUnited States
-
University of FloridaHeermann Anesthesia FoundationCompleted
-
Ocean Spray Cranberries, Inc.Biofortis Innovation ServicesRecruiting